Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Sinovac Biotech Ltd.

    NASDAQ: SVA · Real-Time Price · USD
    6.47
    0.00 (0.00%)
    At close: Feb 11, 2025, 6:18 AM
    0.00%
    Bid n/a
    Market Cap 464.94M
    Revenue (ttm) 728.74M
    Net Income (ttm) -470.56M
    EPS (ttm) 0.971
    PE Ratio (ttm) 6.6632337796086505
    Forward PE n/a
    Analyst n/a
    Ask n/a
    Volume 0
    Avg. Volume (20D) 0
    Open 6.47
    Previous Close 6.47
    Day's Range 6.47 - 6.47
    52-Week Range 6.47 - 6.47
    Beta n/a

    About SVA

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol SVA
    Website n/a
    Full Company Profile
    news image

    1 month ago · businesswire.com

    SINOVAC Board Sets the Record Straight on July 8 Special Meeting of Shareholders

    BEIJING--(BUSINESS WIRE)--The Board of Directors of SINOVAC Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”) today issued the following update to set the record straight regarding the Special M...

    news image

    1 month ago · businesswire.com

    Newly Elected Directors of Sinovac Hold the First Board Meeting

    BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ: SVA) (SINOVAC or the Company), a leading provider of biopharmaceutical products in China, today announced the new board of directors of the Comp...

    news image

    1 month ago · businesswire.com

    SINOVAC Board of Directors Strongly Denounces Deceptive and Illegal Claims by SAIF and the Imposter Former Board

    BEIJING--(BUSINESS WIRE)--The Board of Directors of SINOVAC Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading biopharmaceutical company in China, categorically rejects the recent dece...

    news image

    1 month ago · businesswire.com

    SINOVAC Board of Directors Provides Update on Status of US$55.00 Special Cash Dividend Payment

    BEIJING--(BUSINESS WIRE)--The Board of Directors of SINOVAC Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that the...

    news image

    1 month ago · businesswire.com

    SINOVAC Board of Directors Announces Adjournment of Special Meeting of Shareholders Until Appropriate Court Can Make a Final Decision on the Validity of the PIPE Shares

    BEIJING--(BUSINESS WIRE)--The Board of Directors of SINOVAC Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that the...

    news image

    1 month ago · businesswire.com

    Appeal Decision By Eastern Caribbean Supreme Court Supports Right of Prime Success and Vivo Capital to Participate in Critical Sinovac Biotech Shareholder Vote

    PALO ALTO, Calif.--(BUSINESS WIRE)--Vivo Capital (“Vivo” or “we”), a leading global investment firm focused exclusively on healthcare and life sciences and a long term shareholder of Sinovac Biotech L...

    news image

    1 month ago · businesswire.com

    Final Reminder for SINOVAC Shareholders to Vote the WHITE Proxy Card “AGAINST” Misguided Proposals 1 and 2

    BEIJING--(BUSINESS WIRE)--The Board of Directors of SINOVAC Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today sent shareholders ...

    news image

    1 month ago · businesswire.com

    Federal Court in Massachusetts Denies Vivo Capital's Petition for Relief on SINOVAC

    BEIJING--(BUSINESS WIRE)--The Board of Directors of SINOVAC Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that on ...

    news image

    1 month ago · businesswire.com

    Leading Independent Proxy Advisory Firm ISS Joins Glass Lewis in Recommending Shareholders Vote to Keep the Current SINOVAC Board in Place

    BEIJING--(BUSINESS WIRE)--The Board of Directors of SINOVAC Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that lea...

    news image

    1 month ago · businesswire.com

    CORRECTING and REPLACING SAIF Partners: Now is Your Last Chance to Vote for Board Change at Sinovac

    NEW YORK--(BUSINESS WIRE)--Third paragraph, second sentence of release should read: These include the current Board's failure to actively engage with management, its lack of sound financial reasoning ...

    Add to Watchlist